What the Research Says
Kwak et al. studied 5 g/day chlorella for eight weeks in 23 adults versus 28 controls. NK-cell activity and selected cytokine markers increased, but infection rates and clinical immune benefit were not established. [1]
Ryu et al. randomized 63 adults with mild hypercholesterolemia for four weeks. The abstract reports improvements mainly in total cholesterol and triglycerides, not a significant LDL result. A 2022 review of ten trials (539 participants) found modest total and LDL reductions, but only four trials had low risk of bias and only two reported testing product content and contamination. A 2025 review found neutral lipid and blood-pressure effects. [2][7][8]
The hepatitis C study enrolled 18 adults without a randomized control group. ALT decreased, while viral-load and AST changes were not statistically significant. It cannot establish treatment efficacy. A newer fatty-liver review rated its evidence very low certainty, limiting conclusions despite favorable biomarker estimates. [3][10]
Human evidence does not establish heavy-metal detoxification or the claimed tissue-repair benefits of a branded or loosely defined growth-factor fraction. Nutrient absorption and composition vary with the product and processing.


